Showing results (431-440 of 5,653) with videos related to

Sort By:
Pageof 566
Drug Design, Development and Therapy|August 9, 2022
Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental VerificationYanqiu He, Cheng Hu, Shiyu Liu, et al.
Drug Design, Development and Therapy|August 4, 2022
Study of the Mechanism of Antiemetic Effect of Lavandula angustifolia Mill. Essential Oil Based on Ca2+/CaMKII/ERK1/2 PathwayJia Li, Xiao Wang, Shining Xun, et al.
Drug Design, Development and Therapy|August 4, 2022
Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver DysfunctionXiao-Nan Gao, Xu-Yang Nie, Jing-Lin Gao, et al.
Drug Design, Development and Therapy|August 19, 2022
Intravenous Lidocaine Significantly Reduces the Propofol Dose in Elderly Patients Undergoing Gastroscopy: A Randomized Controlled TrialSong Hu, Mingxia Wang, Siyu Li, et al.
Drug Design, Development and Therapy|August 10, 2022
Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal TransitionXingxing Chen, Xue Xia, Tiancheng Dong, et al.
Drug Design, Development and Therapy|August 10, 2022
Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal DialysisXiaosheng Li, Jie Zheng, Jian Wang, et al.
Drug Design, Development and Therapy|May 19, 2021
Inhibitory Effect of Lactococcus lactis subsp. lactis HFY14 on Diphenoxylate-Induced Constipation in Mice by Regulating the VIP-cAMP-PKA-AQP3 Signaling PathwayQian Tan, Jing Hu, Yujing Zhou, et al.
Drug Design, Development and Therapy|May 20, 2021
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in RatsShanji Nan, Peng Wang, Yizhi Zhang, et al.
Drug Design, Development and Therapy|May 12, 2021
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and CureOsama A Badary, Marwa S Hamza, Rajiv Tikamdas
Drug Design, Development and Therapy|May 12, 2021
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II StudyHui Li, Shukui Qin, Ying Liu, et al.
Pageof 566